Themis Medicare reported a consolidated net profit of ₹1.14 crore for the year ended March 31, 2026, a sharp drop from the previous year. Standalone operations incurred a net loss of ₹14.19 crore. The company recommended a final dividend of Re. 0.50 per share.
Themis Medicare Reports Mixed Financials for FY26, Recommends Dividend
Consolidated Net Profit: ₹1.14 crore Standalone Net Loss: ₹-14.19 crore Reader Takeaway: Profitability contraction signals pressure, but a dividend payout offers some shareholder return. ## What just happened Themis Medicare Limited announced its audited financial results for the year ended March 31, 2026. The company reported a consolidated net profit of ₹1.14 crore (₹114.37 lakh), a significant decrease from the previous year. On a standalone basis, the company incurred a net loss of ₹14.19 crore (₹1,418.55 lakh), a reversal from a profit in the prior fiscal year. ## Why this matters Investors are closely watching profitability trends. The sharp decline in consolidated profit and the shift to a standalone net loss indicate potential operational or financial challenges. However, the Board has recommended a final dividend of Re. 0.50 per equity share, subject to shareholder approval, which may provide some immediate return to investors. ## The backstory For the fiscal year 2025, Themis Medicare had reported a standalone profit of ₹23.92 crore and a consolidated net profit of ₹29.83 crore. The revenue from operations for FY26 stood at ₹342.24 crore, a decrease of 15.6% from ₹405.51 crore in FY25 on a standalone basis. ## What changes now Shareholders will need to assess the reasons behind the significant profitability contraction. The company highlighted exceptional items impacting the results, including ₹0.87 crore related to Labour Codes and ₹1.29 crore for write-offs concerning the dissolution of its subsidiary, M/s. Carpo Medicals Limited. These one-time costs have affected the reported annual profits. ## Risks to watch The primary risk lies in the continued pressure on profit margins. The decline in revenue coupled with potentially sticky cost structures, exacerbated by regulatory-driven costs like Labour Codes, could impact future profitability. Investors should monitor the company's ability to manage its costs effectively and improve operational efficiency. ## Peer comparison Information on direct peers' latest financial results is not available in this filing. ## Context metrics (time-bound) Standalone revenue for FY26 was ₹342.24 crore, down from ₹405.51 crore in FY25. Consolidated revenue also stood at ₹342.24 crore for FY26. ## What to track next Investors should look for management commentary on strategies to improve standalone profitability, cost management initiatives, and the impact of new labour regulations on operational expenses in the upcoming quarters. The approval and payout of the recommended dividend will also be a point of interest.
Get stock alerts instantly on WhatsApp
Quarterly results, bulk deals, concall updates and major announcements delivered in real time.
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.
